In short: The global syringes market was valued at USD 10.56 billion in 2016. Some estimate that this market will grow to USD 16.99 billion by 2021, i.e. with an annual compound growth rate of 8.7%.
This is the second in a series of blog posts on this topic. The previous post in this series is entitled:
The global syringes market is segmented into two broad categories, namely:
- sterilisable/reusable syringes, and
- disposable syringes.
Reused equipment poses a continued challenge. The World Health Organization (WHO) and Safe Injection Global Network (SIGN) launched an initiative to promote rational and safe use of injections. Two of the three main objectives are:
- A) preventing needlestick injuries and reuse, and
- B) better ensuring injection safety through the use of safety engineered injection devices.
Source: Injection safety policy and global campaign
Check out WHAT IS A SAFE INJECTION?
Based on efforts by the WHO and other international organisations, it comes as little surprise that by 2016, disposable syringes made up more than 50% of the total market.
A big reason for this is the high infection risks associated with reusable syringes. The WHO estimates that reusing syringes leads to more than two million people being infected with diseases each year, including HIV and hepatitis.
Use of the same syringe or needle to give injections to more than one person is driving the spread of a number of deadly infectious diseases worldwide.
Another reason for the increasing demand is the call for “smart” syringes by the WHO. It makes patients’ increasing desire for self-administration of some drugs, such as in the case of Type 1 diabetes, easier to satisfy.
Patients want a safe way to dispose of such needles, as they do not appreciate the added risk of possibly injuring themselves. “Smart” syringes make it easier to administer such injections in less than ideal circumstances, and make everyone safer.
Below we discuss some of the trends in the syringe market.
Forecast Market Demand
Forecasting market demands is always difficult. We are likely to miss the mark or get numbers that turn out to be totally wrong later on.
Nevertheless, William Barnett suggests that we take Four Steps to Forecast Total Market Demand. We outline these below.
1. Defining the market
The market includes hospitals, general practitioners, clinics, governments (e.g., the UK), and users that self-administer injections.
For example, total-market demand for disposable syringes nationally depends in part on the number of people, their needs (e.g., aging population, growing number of diabetes cases), and needs and habits (e.g., nutrition, doing daily exercises, etc.).
Hospitals will be guided by price considerations, and of course, regulations requiring them to follow certain best practice standards.
2. What are the main components of the demand
Once we have defined the market, we need to figure out what demand we can expect from such a market.
We can divide demand into different components, for example reusable syringes and one-time usable syringes. We can further divide this market into client or customer groups, such as:
- organisations (e.g., private or public hospitals),
- medical clinics,
- non-governmental organisations (NGOs),
- small clinics with fewer than six general practitioners, and
- private users.
Each of the above groups can, for instance, be further divided by usage levels. For instance, a diabetic user might require two or more smart syringes each day.
3. Forecasting the drivers of demand
The main shift will come from governments asking their healthcare providers to use smart syringes.
For example, in the future, unless a prescription specifies another type of syringe, the pharmacist will automatically give the patient a safety-engineered smart syringe with their prescription. This could be in case of patients that need a regular insulin shot for Type 1 diabetes.
The World Health Organization (WHO) has stipulated the following:
By 2020 transition to the exclusive use, where appropriate, of safety-engineered injection devices with re-use prevention and sharps (needle) injury prevention.
— Making all injections safe. World Health Organizationn 2015.
Fact. The LomMedical line of safety-engineered syringes prevent reuse and sharps (needle) injury as a standard function.
4. Conduct sensitivity analyses
In his article, Four Steps to Forecast Total Market Demand, William Barnett suggests that sensitivity analyses help one better understand the most critical assumptions and gauge risks to the baseline forecast.
At one level, we can conduct a sensitivity analysis by simply varying assumptions and quantifying their impact on demand. But a more targeted approach usually provides better insight.
It is better to define the major risks, such as a large market not implementing the WHO demand for safety-engineered or “smart” syringes. The likelihood of this occurring then also needs to be considered.
Demand for smart syringes
Considering the above four steps. How trustworthy are the estimates we find regarding market size and / or demand?
This is hard to say, but the World Health Organization (WHO) estimates that there are 16 billion injections administered every year. These numbers are largely based on sales figures from syringe manufacturers.
The WHO also points out that around 5% of these injections are for immunizing children and adults. Another 5% are for other procedures, such as blood transfusions.
The remaining 90% of injections are given into muscle (intramuscular route) or skin (subcutaneous or intradermal route) to administer medicines.
— WHO calls for worldwide use of “smart” syringes (Feb 2015).
By 2021, the WHO wants “smart” syringes to dominate the market.
If the WHO’s policy suggestions are implemented, the market could grow to USD 16.99 billion by 2021, i.e. with an annual compound growth rate of 8.7%. But how much of this number will be “smart” syringes is unclear.
How much of this number will be spent on safety-engineered smart syringes is unknown. Depending upon what we read, the numbers diverge quite a bit:
Smart Syringes Market by syringes Type (Auto disable, Active safety, Passive safety), Application (Drug delivery, Vaccination, Blood specimen collection) and End User, (Hospitals and HMOs, Diabetic patients, Family practices, Psychiatrics) – Global Opportunity Analysis and Industry Forecast, 2014 – 2020. Retrieved July 1, 2017 from https://www.alliedmarketresearch.com/smart-syringes-market
Have your say – join the conversation
What is your opinion?
- How do you calculate your product’s market volume?
- What risks do you see with the market growth regarding smart syringes?
- Will the World Health Organization’s demand for the use of “smart” syringes be implemented worldwide by 2020?
Looking forward to your comments.